SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041122
Filing Date
2019-11-06
Accepted
2019-11-06 17:04:52
Documents
52
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrca-10q_20190930.htm 10-Q 2043890
2 EX-10.2 vrca-ex102_131.htm EX-10.2 20161
3 EX-31.1 vrca-ex311_7.htm EX-31.1 15038
4 EX-31.2 vrca-ex312_6.htm EX-31.2 15021
5 EX-32.1 vrca-ex321_8.htm EX-32.1 11203
  Complete submission text file 0001564590-19-041122.txt   6012996

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vrca-20190930.xml EX-101.INS 1284669
7 XBRL TAXONOMY EXTENSION SCHEMA vrca-20190930.xsd EX-101.SCH 32331
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vrca-20190930_cal.xml EX-101.CAL 40741
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vrca-20190930_def.xml EX-101.DEF 118408
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20190930_lab.xml EX-101.LAB 286661
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20190930_pre.xml EX-101.PRE 210212
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38529 | Film No.: 191197134
SIC: 2834 Pharmaceutical Preparations